Heterpphile Antibody Test
- UID
- IMP/IVD/2018/000005_c2f1d1ae08ba2f5757d8858b8758cd81_1a97f75e7784961fbee8bc02cedfb54a
- Device class
- Class B
- Brand name
- Pathozyme® Ultrasensitive TSH
- License holder
- Omega DX (Asia) Private Limited
- Approving authority
- CDSCO
- Product information
- Avitex® IM is an in-vitro diagnostic kit used for detection and semi-quantitative measurement of the heterophile antibody associated with infectious mononucleosis (Pathozyme® Ultrasensitive TSH)
Heterpphile Antibody Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2018/000005_c2f1d1ae08ba2f5757d8858b8758cd81_1a97f75e7784961fbee8bc02cedfb54a. This device is marketed under the brand name Pathozyme® Ultrasensitive TSH. The license holder is Omega DX (Asia) Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.